Evidence map›Paper›PMID 42299705›Full record

ArticlePrimary health care research & development2026

Emily Gard Marshall, Lauren Renaud, Maria Mathews, Andrea Bishop, Bobbi Morrison, Natalie Kennie-Kaulbach, Shanna Trenaman, Abraham Munene, Susan Bowles, Isaac Bai and 1 more

Abstract read
In one paragraph

Article in Primary health care research & development, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Emily Gard MarshallFamily Medicine, Dalhousie University, Halifax, Canada.ORCID 0000-0001-8327-0329
Lauren RenaudFamily Medicine, Dalhousie University, Halifax, Canada.ORCID 0000-0002-0802-0140
Maria MathewsFamily Medicine, University of Western Ontario: Western University, London, Canada.ORCID 0000-0002-5174-104X
Andrea BishopNova Scotia Pharmacy Regulator, Halifax, Canada.
Bobbi MorrisonMarketing & Enterprise Systems, StFX: St Francis Xavier University, Antigonish, Canada.
Natalie Kennie-KaulbachCollege of Pharmacy, https://ror.org/01e6qks80Dalhousie University, Halifax, Canada.ORCID 0000-0002-4792-9365
Shanna TrenamanCollege of Pharmacy, https://ror.org/01e6qks80Dalhousie University, Halifax, Canada.ORCID 0000-0002-7982-4437
Abraham MuneneFamily Medicine, Dalhousie University, Halifax, Canada.ORCID 0000-0001-9546-3574
Susan BowlesCollege of Pharmacy, https://ror.org/01e6qks80Dalhousie University, Halifax, Canada.
Isaac BaiDepartment of Medicine, Queen's University - Kingston Campus: Queen's University, Kingston, Canada.ORCID 0000-0003-4812-8428
Jennifer E IsenorFamily Medicine, Dalhousie University, Halifax, Canada.ORCID 0000-0003-1648-7362

Funding

Non-US Government Research Support type
6 · The paper itself

Abstract

aimThe aim of our study was to understand how routine pharmacy practice was impacted during the COVID-19 pandemic and the consequences for patient access.

backgroundCommunity pharmacists are among the most accessible primary care providers, playing a vital role in primary care access for patients. During the COVID-19 pandemic, community pharmacists took on numerous additional roles to support safe primary care access. As health systems are in the latter stages of recovery from the pandemic, understanding how the pandemic impacted routine community pharmacy practice and the repercussions for post-pandemic practice is important.

methodsBetween September 2020 and January 2021, we interviewed 11 pharmacists working in community pharmacies in Nova Scotia, Canada. We thematically analyzed qualitative data pertaining to pharmacists' perceptions of pandemic impacts on providers, patients, and pharmacy practice.

findingsThe COVID-19 pandemic greatly impacted community pharmacy practice, patients, and community pharmacists. Participants recommended maintaining some of the community pharmacy practice changes and suggested that continuing to expand the scope of practice for pharmacists is essential to meeting population health needs moving forward. Pharmacists recognize and are willing to maintain the essential roles they have assumed in facilitating patient access to primary care. Decision-makers should consider providing the necessary supports (e.g., communication software) and funding support to enable the full scope of community pharmacist practice.

Indexed as

Community Pharmacy ServicesCOVID-19PharmacistsProfessional RoleAccess to Primary CareAttitude of Health PersonnelHumansNova ScotiaPandemicsPrimary Health CareQualitative ResearchSARS-CoV-2COVID-19pandemicspharmacistspolicyprimary care

Identifiers

PMID42299705
PMCPMC13280592

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.